Evaluating the effects of proton therapy on pediatric cancer patients
Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy
This study tests how proton therapy affects the quality of life and side effects in kids with cancer to help improve their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT02644993 on ClinicalTrials.gov |
What this trial studies
This study aims to assess how proton therapy impacts the quality of life and long-term normal tissue toxicities in pediatric cancer patients. By analyzing these effects, researchers hope to develop a predictive model that can inform risk-adapted treatment strategies tailored for this population. The study will involve patients under 18 years old who are scheduled to receive proton therapy at Samsung Medical Center. The findings could lead to improved treatment protocols and better outcomes for young patients.
Who should consider this trial
Good fit: Ideal candidates for this study are pediatric patients under 18 years old who are set to receive proton therapy.
Not a fit: Patients who refuse to participate in the cohort study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life and survival rates for pediatric cancer patients undergoing proton therapy.
How similar studies have performed: While there have been studies on proton therapy, this specific approach focusing on quality of life and long-term toxicities in pediatric patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * less than 18 years of age * patient who is planned to receive proton therapy at Samsung Medical Center * Informed consent Exclusion Criteria: * Refuse to participate this cohort study
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Do Hoon Lim, MD, PhD — Proton therapy center, Samsung Medical Center
- Study coordinator: Do Hoon Lim, MD, PhD
- Email: dh8.lim@samsung.net
- Phone: 82-2-3410-2612
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.